Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway
Xiaoxuan Zhao(Dalian Dermatosis Hospital), Jincheng Song(Dalian Medical University)
Cited by 9
Related Papers
Perlecan: Roles in osteoarthritis and potential treating target
|Life Sciences|2022|10